RXRX
Price
$4.22
Change
-$0.02 (-0.47%)
Updated
Apr 7, 02:58 PM (EDT)
Capitalization
1.7B
30 days until earnings call
TLPPF
Price
$13.65
Change
-$2.40 (-14.95%)
Updated
Apr 4 closing price
Capitalization
4.95B
Ad is loading...

RXRX vs TLPPF

Header iconRXRX vs TLPPF Comparison
Open Charts RXRX vs TLPPFBanner chart's image
Recursion Pharmaceuticals
Price$4.22
Change-$0.02 (-0.47%)
Volume$52.29K
Capitalization1.7B
Telix Pharmaceutical
Price$13.65
Change-$2.40 (-14.95%)
Volume$8.66K
Capitalization4.95B
RXRX vs TLPPF Comparison Chart
Loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RXRX vs. TLPPF commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a StrongBuy and TLPPF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (RXRX: $4.24 vs. TLPPF: $13.65)
Brand notoriety: RXRX and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 112% vs. TLPPF: 303%
Market capitalization -- RXRX: $1.7B vs. TLPPF: $4.95B
RXRX [@Biotechnology] is valued at $1.7B. TLPPF’s [@Biotechnology] market capitalization is $4.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 0 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • RXRX’s FA Score: 0 green, 5 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, TLPPF is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 4 TA indicator(s) are bullish.

  • RXRX’s TA Score: 4 bullish, 4 bearish.

Price Growth

RXRX (@Biotechnology) experienced а -27.02% price change this week, while TLPPF (@Biotechnology) price change was -20.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.52%. For the same industry, the average monthly price growth was -18.01%, and the average quarterly price growth was -17.38%.

Reported Earning Dates

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-9.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($4.95B) has a higher market cap than RXRX($1.7B). TLPPF YTD gains are higher at: -8.815 vs. RXRX (-37.278). TLPPF has higher annual earnings (EBITDA): 92.5M vs. RXRX (-426.72M). TLPPF has more cash in the bank: 710M vs. RXRX (594M). RXRX has less debt than TLPPF: RXRX (108M) vs TLPPF (581M). TLPPF has higher revenues than RXRX: TLPPF (783M) vs RXRX (58.5M).
RXRXTLPPFRXRX / TLPPF
Capitalization1.7B4.95B34%
EBITDA-426.72M92.5M-461%
Gain YTD-37.278-8.815423%
P/E RatioN/A150.77-
Revenue58.5M783M7%
Total Cash594M710M84%
Total Debt108M581M19%
TECHNICAL ANALYSIS
Technical Analysis
RXRX
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Ad is loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PREQX5.75-0.28
-4.64%
PACE Global Real Estate Securities P
PRNHX44.66-2.38
-5.06%
T. Rowe Price New Horizons
RDLCX7.36-0.44
-5.64%
Columbia Disciplined Growth C
OCIEX12.07-0.75
-5.85%
Optimum International C
CSRYX32.55-2.35
-6.73%
Columbia Select Large Cap Value Inst3

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-11.85%
CRSP - RXRX
69%
Closely correlated
-0.03%
BEAM - RXRX
64%
Loosely correlated
-7.23%
NTLA - RXRX
59%
Loosely correlated
-3.77%
PRME - RXRX
58%
Loosely correlated
-12.42%
ABSI - RXRX
55%
Loosely correlated
+2.01%
More

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and GLMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and GLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
-14.92%
GLMD - TLPPF
25%
Poorly correlated
-8.22%
DNLI - TLPPF
24%
Poorly correlated
-7.90%
BEAM - TLPPF
24%
Poorly correlated
-7.23%
RXRX - TLPPF
23%
Poorly correlated
-11.85%
JANX - TLPPF
23%
Poorly correlated
-4.52%
More